News | Prostate Cancer | January 18, 2017

PI-RADS Named Best Clinical Research Paper by European Urology

Prostate Imaging Reporting and Data System provides standardized reporting scheme

prostate cancer, PI-RADS, best clinical research paper, European Urology

January 18, 2017 — An article promoting standardized imaging efforts to improve diagnosis and treatment of prostate cancer has been selected as the best clinical research paper published in European Urology

“PI-RADS Prostate Imaging — Reporting and Data System: 2015, Version 2,” written by members of the MR Prostate Imaging Reporting and Data System (PI-RADS) Steering Committee, was published January 2016 in the official journal of the European Association of Urology (EAU). The article provides updated information for the acquisition and standardized interpretation and reporting of multiparametric magnetic resonance imaging (MRI) of the prostate to detect potentially life-threatening cancers.

“Since the publication of this paper last year, the newest version of PI-RADS has been welcomed with open arms and rapidly implemented by the prostate cancer medical community. The positive impact has been tremendous on both clinical care and research concerning the risk of clinically significant prostate cancer that may require biopsy and treatment,” said Jeffrey C. Weinreb, M.D., FACR, co-chair of the MR Prostate Imaging Reporting and Data System (PI-RADS) Steering Committee. Written for medical professionals, the online document along with the European Urology article represent an international scientific consensus, he added. Weinreb noted the steering committee was honored that its efforts received this international distinction. The award will be presented at the EAU annual meeting in March.

The American College of Radiology (ACR) formed a joint effort with AdMeTech Foundation and the European Society of Urogenital Radiology (ESUR) to expedite the transfer of high-quality MRI from laboratories to patients to address a major need in prostate cancer care — reducing unnecessary biopsies and treatment.

Members of the steering committee and authors of the journal article include Weinreb; Jelle O. Barentsz, M.D., Ph.D. (co-chair); Peter L. Choyke, M.D., FACR; François Cornud, M.D.; Masoom A. Haider, M.D.; Katarzyna J. Macura, M.D., Ph.D., FACR; Daniel Margolis, M.D.; Mitchell D. Schnall, M.D., Ph.D., FACR; Clare M. Tempany, M.D.; Harriet C. Thoeny, M.D.; and Sadhna Verma, M.D.

For more information: www.europeanurology.com

References

Weinreb, J.C., Barentsz, J.O., Choyke, P.L., Cornud, F., et al. "PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2," European Urology. Published Jan. 1, 2016. DOI: 10.1016/j.eururo.2015.08.052

Related Content

Long-term Hormone Therapy Increases Mortality Risk for Low-PSA Men After Prostate Surgery
News | Prostate Cancer | September 16, 2019
Secondary analysis of a recent clinical trial that changed the standard of care for men with recurring prostate cancer...
Isoray to Spotlight Cesium-131 Advances at ASTRO Annual Meeting
News | Brachytherapy Systems | September 13, 2019
Isoray Inc. announced it will spotlight the growing cancer treatment applications of Cesium-131 brachytherapy at the...
The irregularly marginated left tumor mass that bulges the lateral capsule appears three times the volume on the multiplanar 3-D/4-D image reconstruction and shows complete extraprostatic extension

Figure 1. 2-D (top) vs 3-D (bottom). The irregularly marginated left tumor mass that bulges the lateral capsule appears three times the volume on the multiplanar 3-D/4-D image reconstruction and shows complete extraprostatic extension. Note: This anterolateral lesion is not clinically palpable.

Feature | Prostate Cancer | September 05, 2019 | By Robert Bard, M.D., DABR, FASLM
Extracapsular extension (ECE) is a major clinical indicator for brachytherapy or external beam treatment of prostate
Surging Demand for Image-guided, Stereotactic Radiation Therapy Driving Fiducial Marker Growth
News | Radiation Therapy | August 22, 2019
As fiducial markers gain traction in parallel to rising incidences of various cancer affecting lung, prostate, abdomen...
Videos | Treatment Planning | August 21, 2019
This is an example of the Mirada DLCExpert deep learning software that automatically identifies organs, segments and
Improved Imaging Technique Could Increase Chances of Prostate Cancer Survival
News | Prostate Cancer | August 20, 2019
According to the American Cancer Society, approximately one in nine men will be diagnosed with prostate cancer in their...
Profound Medical Receives U.S. FDA 510(k) Clearance for Tulsa-Pro
Technology | Interventional Radiology | August 16, 2019
Profound Medical Corp. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to...
Efficacy of Isoray's Cesium Blu Showcased in Recent Studies
News | Brachytherapy Systems | August 14, 2019
August 14, 2019 — Isoray announced a trio of studies recently reported at scientific meetings and published in medica
Videos | Radiology Business | August 02, 2019
Association for Medical Imaging Management (AHRA) President ...